143 related articles for article (PubMed ID: 15131469)
1. Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection.
Gibb DM; Duong T; Leclezio VA; Walker AS; Verweel G; Dunn DT;
Pediatr Infect Dis J; 2004 May; 23(5):446-50. PubMed ID: 15131469
[TBL] [Abstract][Full Text] [Related]
2. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.
Ananworanich J; Siangphoe U; Hill A; Cardiello P; Apateerapong W; Hirschel B; Mahanontharit A; Ubolyam S; Cooper D; Phanuphak P; Ruxrungtham K
J Acquir Immune Defic Syndr; 2005 Aug; 39(5):523-9. PubMed ID: 16044002
[TBL] [Abstract][Full Text] [Related]
4. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.
Walker AS; Doerholt K; Sharland M; Gibb DM;
AIDS; 2004 Sep; 18(14):1915-24. PubMed ID: 15353977
[TBL] [Abstract][Full Text] [Related]
5. [Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment].
Pavie J; Porcher R; Fournier S; André F; Tournoux C; Palmer P; Rabian C; Jean-Michel M
Presse Med; 2005 Jun; 34(10 Suppl):1S8-13. PubMed ID: 16025661
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.
Mata RC; Viciana P; de Alarcón A; López-Cortés LF; Gómez-Vera J; Trastoy M; Cisneros JM
AIDS Patient Care STDS; 2005 Sep; 19(9):550-62. PubMed ID: 16164382
[TBL] [Abstract][Full Text] [Related]
7. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
Fagard C; Oxenius A; Günthard H; Garcia F; Le Braz M; Mestre G; Battegay M; Furrer H; Vernazza P; Bernasconi E; Telenti A; Weber R; Leduc D; Yerly S; Price D; Dawson SJ; Klimkait T; Perneger TV; McLean A; Clotet B; Gatell JM; Perrin L; Plana M; Phillips R; Hirschel B;
Arch Intern Med; 2003 May; 163(10):1220-6. PubMed ID: 12767960
[TBL] [Abstract][Full Text] [Related]
8. Response to planned treatment interruptions in HIV infection varies across childhood.
Paediatric European Network for Treatment of AIDS
AIDS; 2010 Jan; 24(2):231-41. PubMed ID: 20010073
[TBL] [Abstract][Full Text] [Related]
9. Response to highly active antiretroviral therapy according to duration of HIV infection.
Pezzotti P; Pappagallo M; Phillips AN; Boros S; Valdarchi C; Sinicco A; Zaccarelli M; Rezza G;
J Acquir Immune Defic Syndr; 2001 Apr; 26(5):473-9. PubMed ID: 11391168
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
11. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
Palacios GC; Sanchez LM; Briones E; Ramirez TJ; Castillo H; Rivera LG; Vazquez CA; Rodriguez-Padilla C; Holodniy M
Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895
[TBL] [Abstract][Full Text] [Related]
12. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.
Judd A; Doerholt K; Tookey PA; Sharland M; Riordan A; Menson E; Novelli V; Lyall EG; Masters J; Tudor-Williams G; Duong T; Gibb DM; ;
Clin Infect Dis; 2007 Oct; 45(7):918-24. PubMed ID: 17806062
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
14. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.
Puthanakit T; Kerr S; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana V
Pediatr Infect Dis J; 2009 Jun; 28(6):488-92. PubMed ID: 19504731
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of suspending HAART in selected patients with controlled HIV replication.
Jacobs B; Neil N; Aboulafia DM
AIDS Patient Care STDS; 2005 Jul; 19(7):429-38. PubMed ID: 16053400
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
17. Influence of prior structured treatment interruptions on the length of time without antiretroviral treatment in chronically HIV-infected subjects.
Moltó J; Ruiz L; Romeu J; Martínez-Picado J; Negredo E; Tural C; Sirera G; Clotet B
AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1283-8. PubMed ID: 15650419
[TBL] [Abstract][Full Text] [Related]
18. Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: effects on leptin and TNF-alpha.
Arjona MM; Pérez-Cano R; Garcia-Juárez R; Martín-Aspas A; del Alamo CF; Girón-González JA
AIDS Res Hum Retroviruses; 2006 Apr; 22(4):307-14. PubMed ID: 16623632
[TBL] [Abstract][Full Text] [Related]
19. Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study.
Taffé P; Rickenbach M; Hirschel B; Opravil M; Furrer H; Janin P; Bugnon F; Ledergerber B; Wagels T; Sudre P;
AIDS; 2002 Mar; 16(5):747-55. PubMed ID: 11964531
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
